458 related articles for article (PubMed ID: 33185489)
1. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
Maroufi F; Maali A; Abdollahpour-Alitappeh M; Ahmadi MH; Azad M
Epigenomics; 2020 Oct; 12(20):1845-1859. PubMed ID: 33185489
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas mediated epigenome editing for cancer therapy.
Ansari I; Chaturvedi A; Chitkara D; Singh S
Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 in epigenetics studies of health and disease.
Sar P; Dalai S
Prog Mol Biol Transl Sci; 2021; 181():309-343. PubMed ID: 34127198
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
5. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.
Syding LA; Nickl P; Kasparek P; Sedlacek R
Cells; 2020 Apr; 9(4):. PubMed ID: 32316223
[TBL] [Abstract][Full Text] [Related]
7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
8. A Review on CRISPR-mediated Epigenome Editing: A Future Directive for Therapeutic Management of Cancer.
Chakravarti R; Lenka SK; Gautam A; Singh R; Ravichandiran V; Roy S; Ghosh D
Curr Drug Targets; 2022; 23(8):836-853. PubMed ID: 35078394
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation.
Cai R; Lv R; Shi X; Yang G; Jin J
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834313
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression by altered promoter methylation using a CRISPR/Cas9-mediated epigenetic editing system.
Kang JG; Park JS; Ko JH; Kim YS
Sci Rep; 2019 Aug; 9(1):11960. PubMed ID: 31427598
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic editing: Dissecting chromatin function in context.
Policarpi C; Dabin J; Hackett JA
Bioessays; 2021 May; 43(5):e2000316. PubMed ID: 33724509
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
13. Harnessing targeted DNA methylation and demethylation using dCas9.
Pflueger C; Swain T; Lister R
Essays Biochem; 2019 Dec; 63(6):813-825. PubMed ID: 31724704
[TBL] [Abstract][Full Text] [Related]
14. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-mediated promoter de/methylation technologies for gene regulation.
Sung CK; Yim H
Arch Pharm Res; 2020 Jul; 43(7):705-713. PubMed ID: 32725389
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.
Rahman MM; Tollefsbol TO
Methods; 2021 Mar; 187():77-91. PubMed ID: 32315755
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated epigenetic editing tool: An optimized strategy for targeting de novo DNA methylation with stable status via homology directed repair pathway.
Wang J; Li D; Yang J; Chang L; Zhang R; Li J
Biochimie; 2022 Nov; 202():190-205. PubMed ID: 35921985
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Gene Expression Using dCas9-SunTag Platforms.
Morita S; Horii T; Hatada I
Methods Mol Biol; 2023; 2577():189-195. PubMed ID: 36173574
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies.
Wen WS; Yuan ZM; Ma SJ; Xu J; Yuan DT
Int J Cancer; 2016 Mar; 138(6):1328-36. PubMed ID: 26044706
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy.
Jeffries MA
Clin Immunol; 2018 Nov; 196():49-58. PubMed ID: 29421443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]